| Structure |
Chemical Name |
CAS |
MF |
 |
AZD-9291 |
1421373-65-0 |
C28H33N7O2 |
 |
Masitinib |
790299-79-5 |
C28H30N6OS |
 |
Lenvatinib |
417716-92-8 |
C21H19ClN4O4 |
 |
Linifanib (ABT-869) |
796967-16-3 |
C21H18FN5O |
 |
PELITINIB |
257933-82-7 |
C24H23ClFN5O2 |
 |
Dacomitinib (PF299804) |
1110813-31-4 |
C24H25ClFN5O2 |
 |
Palbociclib |
571190-30-2 |
C24H29N7O2 |
 |
Pazopanib Hydrochloride |
635702-64-6 |
C21H24ClN7O2S |
 |
Cabozantinib |
849217-68-1 |
C28H24FN3O5 |
 |
Tivozanib |
475108-18-0 |
C22H19ClN4O5 |
 |
Afatinib dimaleate |
850140-73-7 |
C28H29ClFN5O7 |
 |
Ceritinib (LDK378) |
1032900-25-6 |
C28H36ClN5O3S |
 |
CO-1686 |
1374640-70-6 |
C27H28F3N7O3 |
 |
NVP-TAE684 |
761439-42-3 |
C30H40ClN7O3S |
 |
Foretinib (GSK1363089) |
849217-64-7 |
C34H34F2N4O6 |
 |
Amuvatinib |
850879-09-3 |
C23H21N5O3S |
 |
Alectinib |
1256580-46-7 |
C30H34N4O2 |
 |
WZ4002 |
1213269-23-8 |
C25H27ClN6O3 |
 |
J&J Ex-61 |
943540-75-8 |
C19H13F2N7 |
 |
AEE788 |
497839-62-0 |
C27H32N6 |
 |
Crenolanib |
670220-88-9 |
C26H29N5O2 |
 |
AC480 (BMS-599626) |
714971-09-2 |
C27H27FN8O3 |
 |
AMG-706 |
857876-30-3 |
C22H29N5O9P2 |
 |
LY 2874455 |
1254473-64-7 |
C21H19Cl2N5O2 |
 |
AP26113 |
1197958-12-5 |
C26H34ClN6O2P |
 |
GW441756 |
504433-23-2 |
C17H13N3O |
 |
Vatalanib Dihydrochloride |
212141-51-0 |
C20H17Cl3N4 |
 |
Momelotinib |
1056634-68-4 |
C23H22N6O2 |
 |
AZD8931 |
848942-61-0 |
C23H25ClFN5O3 |
 |
Cabozantinib Malate |
1140909-48-3 |
C32H30FN3O10 |
 |
Orantinib (SU6668) |
252916-29-3 |
C18H18N2O3 |
 |
XL518 |
934660-93-2 |
C21H21F3IN3O2 |
 |
Tucatinib |
937263-43-9 |
C26H24N8O2 |
 |
SU 11274 |
658084-23-2 |
C28H30ClN5O4S |
 |
Pixantrone Dimaleate |
144675-97-8 |
C21H23N5O6 |
 |
SGX-523 |
1022150-57-7 |
C18H13N7S |
![1-Cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine](/CAS2/GIF/1092788-83-4.gif) |
1-Cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
1092788-83-4 |
C17H17N7 |
 |
AMG-208 |
1002304-34-8 |
C22H17N5O2 |
 |
R428 |
1037624-75-1 |
C30H34N8 |
 |
AG 1478 HYDROCHLORIDE |
153436-53-4 |
C16H14ClN3O2 |
 |
CP-724714 |
537705-08-1 |
C27H27N5O3 |
 |
PD04217903 |
956905-27-4 |
C19H16N8O |
 |
TYRPHOSTIN AG 1024 |
65678-07-1 |
C14H13BrN2O |
 |
AMG 458 |
913376-83-7 |
C30H29N5O5 |
 |
Linsitinib |
867160-71-2 |
C26H23N5O |
 |
Ki8751 |
228559-41-9 |
C24H18F3N3O4 |
 |
IGF-1R Inhibitor II, N-(5-Chloro-2-methoxyphenyl)-Nμ-(2-methylquinolin-4-yl)urea |
196868-63-0 |
C18H16ClN3O2 |
![(2R)-1-[[5-[(Z)-[5-[[(2,6-DICHLOROPHENYL)METHYL]SULFONYL]-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE]METHYL]-2,4-DIMETHYL-1H-PYRROL-3-YL]CARBONYL]-2-(1-PYRROLIDINYLMETHYL)PYRROLIDINE](/CAS/GIF/477575-56-7.gif) |
(2R)-1-[[5-[(Z)-[5-[[(2,6-DICHLOROPHENYL)METHYL]SULFONYL]-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE]METHYL]-2,4-DIMETHYL-1H-PYRROL-3-YL]CARBONYL]-2-(1-PYRROLIDINYLMETHYL)PYRROLIDINE |
477575-56-7 |
C32H34Cl2N4O4S |
![1-{2-[5-(2-Methoxy-ethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine](/CAS2/GIF/343787-29-1.gif) |
1-{2-[5-(2-Methoxy-ethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine |
343787-29-1 |
C24H27N5O2 |
![N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide](/CAS2/GIF/875337-44-3.gif) |
N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide |
875337-44-3 |
C26H20FN5O2S2 |
 |
NVP-BHG712 |
940310-85-0 |
C26H20F3N7O |
 |
Apatinib |
811803-05-1 |
C24H23N5O |
 |
TYRPHOSTIN AG 1296 |
146535-11-7 |
C16H14N2O2 |
 |
TYRPHOSTIN AG 879 |
148741-30-4 |
C18H24N2OS |
 |
BMS-754807 |
1001350-96-4 |
C23H24FN9O |
 |
Tie2 kinase inhibitor |
948557-43-5 |
C26H21N3O2S |
 |
BMS-794833 |
1174046-72-0 |
C23H15ClF2N4O3 |
 |
AVL-292 |
1202757-89-8 |
C22H22FN5O3 |
 |
LRRK2-IN-1 |
1234480-84-2 |
C31H38N8O3 |
 |
Golvatinib (E7050) |
928037-13-2 |
C33H37F2N7O4 |
 |
2-(2-ETHYL-2,3-DIHYDRO-2-BENZOFURANYL)-1H-IMIDAZOLE |
189224-48-4 |
C13H14N2O |
 |
Mk-2461 . |
917879-39-1 |
C24H25N5O5S |
 |
WZ8040 |
1214265-57-2 |
C24H25ClN6OS |
 |
Insulin-like Growth Factor-1 Receptor Inhibitor |
468740-43-4 |
C25H26ClN5O3 |
![5-(3-Benzyloxyphenyl)-7-[trans-3-[(pyrrolidin-1-yl)methyl]cyclobutyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine](/CAS/GIF/475488-23-4.gif) |
5-(3-Benzyloxyphenyl)-7-[trans-3-[(pyrrolidin-1-yl)methyl]cyclobutyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
475488-23-4 |
C28H31N5O |
 |
OSI-420 |
183320-51-6 |
C21H22ClN3O4 |
 |
SR 1078 |
1246525-60-9 |
C17H10F9NO2 |
 |
AST-1306 |
1050500-29-2 |
C31H26ClFN4O5S |
 |
Poziotinib (HM781-36B) |
1092364-38-9 |
C23H21Cl2FN4O3 |
 |
AVP-AEW541 |
475489-16-8 |
C27H29N5O |
 |
ALK/IGF1R inhibitor |
1356962-20-3 |
C24H25ClN6O |
 |
ZM 306416 |
690206-97-4 |
C16H13ClFN3O2 |
![3-[(2,4-Dimethylpyrrol-5-yl)methylidenyl]-2-indolinon](/CAS/GIF/194413-58-6.gif) |
3-[(2,4-Dimethylpyrrol-5-yl)methylidenyl]-2-indolinon |
194413-58-6 |
C15H14N2O |
 |
KRN 633 |
286370-15-8 |
C20H21ClN4O4 |
 |
lenvatinib Mesylate |
857890-39-2 |
C22H23ClN4O7S |
 |
OSI-930 |
728033-96-3 |
C22H16F3N3O2S |
 |
NVP-BVU 972 |
1185763-69-2 |
C20H16N6 |
 |
REVERSINE |
656820-32-5 |
C21H27N7O |
 |
PD153035 HCl |
183322-45-4 |
C16H14BrN3O2.HCl |
 |
ARRY-380 |
937265-83-3 |
C29H27N7O4S |
 |
NVP-BSK805 |
1092499-93-8 |
C27H28F2N6O |
![3-(1-Methyl-1H-pyrazol-4-yl)-5-oxo-N-(2-pyridinylmethyl)-5H-benzo[4,5]cyclohepta[1,2-b]pyridine-7-methanesulfonamide](/CAS/GIF/1001917-37-8.gif) |
3-(1-Methyl-1H-pyrazol-4-yl)-5-oxo-N-(2-pyridinylmethyl)-5H-benzo[4,5]cyclohepta[1,2-b]pyridine-7-methanesulfonamide |
1001917-37-8 |
C25H21N5O3S |
![N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine](/CAS/GIF/1097917-15-1.gif) |
N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine |
1097917-15-1 |
C29H40N8O3S |
 |
E-3810 |
1058137-23-7 |
C26H25N3O4 |
 |
GNF 5837 |
1033769-28-6 |
C28H21F4N5O2 |
![5-[3-Methoxy-4-(4-methoxy-benzyloxy)-benzyl]-pyrimidine-2,4-diamine](/CAS2/GIF/870483-87-7.gif) |
5-[3-Methoxy-4-(4-methoxy-benzyloxy)-benzyl]-pyrimidine-2,4-diamine |
870483-87-7 |
C20H22N4O3 |
 |
Tepotinib |
1100598-32-0 |
C29H28N6O2 |
 |
GSK1838705A |
1116235-97-2 |
C27H29FN8O3 |
 |
TAK-285 |
871026-44-7 |
C26H25ClF3N5O3 |
![3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione](/CAS/GIF/905854-02-6.gif) |
3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione |
905854-02-6 |
C23H19N3O2 |
 |
WZ3146 |
1214265-56-1 |
C24H25ClN6O2 |
 |
GDC-0941 Bimesylate |
957054-33-0 |
C24H30N7O6S3 |
 |
Icotinib |
610798-31-7 |
C22H21N3O4 |
 |
UNC2250 |
1493694-70-4 |
C24H36N6O2 |
 |
PD168393 |
194423-15-9 |
C17H13BrN4O |
 |
Capmatinib |
1029712-80-8 |
C23H17FN6O |
![2-ButynaMide, N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]-](/CAS/GIF/194423-06-8.gif) |
2-ButynaMide, N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]- |
194423-06-8 |
C18H13BrN4O |
 |
ZM 323881 hydrochloride |
193000-39-4 |
C22H19ClFN3O2 |
 |
CNX-2006 |
1375465-09-0 |
C26H27F4N7O2 |
 |
SKLB1002 |
1225451-84-2 |
C13H12N4O2S2 |